LACRIMAL IMPLANTS INCLUDING SPLIT AND INSERTABLE DRUG CORE

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20120245539A1
SERIAL NO

13512277

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Lacrimal implants providing secure, wedgable retention within a lacrimal punctum and associated canaliculus of an eye are disclosed. The lacrimal implants can comprise an implant body, including first and second portions, extending from a proximal end of the first portion to a distal end of the second portion. The second portion includes a retention projection. The implant body can also include a cavity longitudinally extending from the proximal end of the first portion toward the second portion, wherein the cavity is shaped and sized to receive an insertable actuator, and wherein the retention projection is configured to bias outward or change orientation when the insertable actuator is seated within the cavity.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MATI THERAPEUTICS INC4317 DUNNING LANE AUSTIN TX 78746

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Scott, David J Redwood City, US 35 1094
Tholfsen, David San Leandro, US 6 469
Zarins, Sascha K Saratoga, US 2 50

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation